Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merin Thomas

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Continuing Education in Nursing|September 10, 2015
Staff Nurses Eliminated Catheter-Associated Urinary Tract Infections in a Neurosurgical Intensive Care UnitSherley John, Merin Thomas, Meghan Cardona, et al.
Annals of Hematology|November 10, 2022
Excess deaths among adults with sickle cell disease in 2020 compared to prior yearsSusanna Curtis, Billett Henny, Starrels Joanna, et al.
American Journal of Hematology|February 20, 2020
Hemoglobin F mitigation of sickle cell complications decreases with agingSeda S Tolu, Morayma Reyes-Gil, Ugochi O Ogu, et al.
American Journal of Hematology|October 17, 2020
L-glutamine use in adults with sickle cell disease: Clinical trials where success meets realityUgochi O Ogu, Merin Thomas, Florence Chan, et al.
Environmental Research|December 18, 2022
Nanovesicle and extracellular polymeric substance synthesis from the remediation of heavy metal ions from soilVivekananda Budamagunta, Nowsheen Shameem, Sivaraj Irusappan, et al.
American Journal of Clinical Pathology|April 19, 2024
Concentration of voxelotor in sickle cell disease can be estimated using electrophoresis and high-performance liquid chromatographySusanna A Curtis, Elana Friedman, Caterina Minniti, et al.
The Lancet. Microbe|November 29, 2024
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UKNicola Borthwick, Natalia Fernandez, Peter J Hayes, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Continuing Education in Nursing|September 10, 2015
Staff Nurses Eliminated Catheter-Associated Urinary Tract Infections in a Neurosurgical Intensive Care UnitSherley John, Merin Thomas, Meghan Cardona, et al.
Annals of Hematology|November 10, 2022
Excess deaths among adults with sickle cell disease in 2020 compared to prior yearsSusanna Curtis, Billett Henny, Starrels Joanna, et al.
American Journal of Hematology|February 20, 2020
Hemoglobin F mitigation of sickle cell complications decreases with agingSeda S Tolu, Morayma Reyes-Gil, Ugochi O Ogu, et al.
American Journal of Hematology|October 17, 2020
L-glutamine use in adults with sickle cell disease: Clinical trials where success meets realityUgochi O Ogu, Merin Thomas, Florence Chan, et al.
Environmental Research|December 18, 2022
Nanovesicle and extracellular polymeric substance synthesis from the remediation of heavy metal ions from soilVivekananda Budamagunta, Nowsheen Shameem, Sivaraj Irusappan, et al.
American Journal of Clinical Pathology|April 19, 2024
Concentration of voxelotor in sickle cell disease can be estimated using electrophoresis and high-performance liquid chromatographySusanna A Curtis, Elana Friedman, Caterina Minniti, et al.
The Lancet. Microbe|November 29, 2024
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UKNicola Borthwick, Natalia Fernandez, Peter J Hayes, et al.
Nature Communications|September 25, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infectionMimi M Hou, Adam C Harding, Natalie M Barber, et al.
Pageof 2